Eileen Monge is an Associate Director of Drug Safety at Eli Lilly and Company, where they have been since 2024. Previously, they managed drug safety at Loxo Oncology and contributed to clinical coding at Genentech. Eileen has extensive experience in clinical trials, particularly in early phase oncology studies, and has held various roles in research coordination and blood services management. With a background in pediatric nursing and a strong skill set in organizational decision-making, they have effectively mentored new staff throughout their career.
This person is not in the org chart
This person is not in any teams
This person is not in any offices